+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Profiling"

Cancer Profiling Market Report 2025 - Product Thumbnail Image

Cancer Profiling Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Cancer Profiling Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Cancer Profiling Market - Forecasts from 2024 to 2029

  • Report
  • August 2024
  • 117 Pages
  • Global
From
From
Cancer / Tumor Profiling - Global Strategic Business Report - Product Thumbnail Image

Cancer / Tumor Profiling - Global Strategic Business Report

  • Report
  • March 2025
  • 376 Pages
  • Global
From
Cancer Tumor Profiling Market Report 2025 - Product Thumbnail Image

Cancer Tumor Profiling Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
From
Cancer Tumor Profiling Market Report and Forecast 2024-2032 - Product Thumbnail Image

Cancer Tumor Profiling Market Report and Forecast 2024-2032

  • Report
  • July 2024
  • 200 Pages
  • Global
From
From
From
From
From
Diagnostic Testing Market - Global Forecast Report 2024-2032 - Product Thumbnail Image

Diagnostic Testing Market - Global Forecast Report 2024-2032

  • Report
  • September 2023
  • 140 Pages
  • Global
From
  • 19 Results (Page 1 of 1)
Loading Indicator

The Cancer Profiling market within the Diagnostics industry is focused on the development of tests that can detect the presence of cancer in a patient. These tests are used to identify the type of cancer, its stage, and the best treatment options. Cancer profiling tests are used to detect genetic mutations, which can help doctors determine the best course of treatment for a patient. These tests are also used to monitor the progress of a patient's cancer treatment. The Cancer Profiling market is highly competitive, with many companies offering a variety of tests. Some of the major players in the market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and Roche. Show Less Read more